Denali Therapeutics vs ImmunoBrain Checkpoint
Denali Therapeutics vs ImmunoBrain Checkpoint, compared side by side on 14 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Denali Therapeutics is on 70/100 and ImmunoBrain Checkpoint on 42/100.
Where each one leads
Denali Therapeutics
- our overall score: 70/100 against 42/100
- domain rating: 57/100 against 35/100
ImmunoBrain Checkpoint
Leads on none of the measures we hold for both companies.
At a glance
| Measure | Denali Therapeutics | ImmunoBrain Checkpoint |
|---|---|---|
| What it is | Biopharmaceutical company developing therapies for neurodegenerative diseases, focusing on crossing the blood-brain barrier. | Biopharmaceutical company targeting neurodegeneration and aging by modulating the immune system. |
| Category | Biotech, HealthTech, Drug Discovery, Neurotech | Healthcare, Immunology, Immunotherapy, Alzheimers |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Software |
| Founded | 2015 | 2016 |
| Headquarters | South San Francisco, United States | Tel Aviv, Israel |
| Status | Active | Active |
Size, funding and growth
| Measure | Denali Therapeutics | ImmunoBrain Checkpoint |
|---|---|---|
| Employees | Not published | 18 |
| Headcount growthLast 12 months | Not published | +17.6% |
| Total funding | $1.0B | Not published |
| Latest round | Royalty Funding | Not published |
| LinkedIn followers | Not published | 1,706 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Denali Therapeutics | ImmunoBrain Checkpoint |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 70/100 | 42/100 |
| Traction | Not published | 13/100 |
| Team | 36/100 | 30/100 |
| Search visibility | Not published | 28/100 |
| Quality | Not published | 58/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (39/100) | F (36/100) |
| Domain ratingLink authority, 0-100 | 57/100 | 35/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Denali Therapeutics | ImmunoBrain Checkpoint |
|---|---|---|
| Hosting | Not detected | Google Cloud |
| CDN | Cloudflare | Not detected |
| CMS | WordPress | WordPress |
| Frameworks | Tailwind CSS | Jquery |
| Analytics | Segment | Google Analytics 4 |
Denali Therapeutics vs ImmunoBrain Checkpoint: common questions
Which is better, Denali Therapeutics or ImmunoBrain Checkpoint?
On our 0-100 score Denali Therapeutics rates higher (70/100 against 42/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 14 data points above: read the rows that match what you are buying for.
How do Denali Therapeutics and ImmunoBrain Checkpoint compare on the numbers?
Denali Therapeutics leads on our overall score (70/100 against 42/100), domain rating (57/100 against 35/100).
Read the full Denali Therapeutics review and pricing or the ImmunoBrain Checkpoint review and pricing. You can also browse other Denali Therapeutics alternatives we track.